| Diabetes Treatment and Management | Lifetime | 13 | CA 3 | 99.88 |
| Diabetes Management and Research | Lifetime | 28 | CA 2 | 99.82 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 45 | CA 3 | 99.78 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 19 | CA 1 | 99.50 |
| Metabolism, Diabetes, and Cancer | Lifetime | 80 | CA 7 | 99.58 |
| Pharmacology and Obesity Treatment | Lifetime | 42 | CA 2 | 99.31 |
| Blood Pressure and Hypertension Studies | Lifetime | 197 | CA 10 | 99.32 |
| Diet and metabolism studies | Lifetime | 409 | CA 16 | 99.20 |
| Cardiovascular Function and Risk Factors | Lifetime | 346 | CA 18 | 99.34 |
| Diabetes and associated disorders | Lifetime | 437 | CA 14 | 98.21 |
| Chronic Kidney Disease and Diabetes | Lifetime | 278 | CA 16 | 98.43 |
| Heart Failure Treatment and Management | Lifetime | 552 | CA 36 | 97.98 |
| Dental Radiography and Imaging | Lifetime | 576 | CA 13 | 97.78 |
| Endodontics and Root Canal Treatments | Lifetime | 347 | CA 11 | 97.87 |
| Diabetes Management and Education | Lifetime | 397 | CA 26 | 96.26 |
| Thyroid Disorders and Treatments | Lifetime | 630 | CA 14 | 96.15 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 956 | CA 41 | 94.77 |
| Gestational Diabetes Research and Management | Lifetime | 936 | CA 67 | 95.14 |
| Nutrition, Genetics, and Disease | Lifetime | 678 | CA 26 | 93.15 |
| GDF15 and Related Biomarkers | Lifetime | 185 | CA 7 | 90.71 |
| Occupational health in dentistry | Lifetime | 562 | CA 23 | 82.56 |
| Diabetes Management and Research | 2021-2025 | 39 | CA 2 | 99.32 |
| Diabetes Treatment and Management | 2021-2025 | 56 | CA 4 | 99.44 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 51 | CA 6 | 98.37 |
| Pancreatic function and diabetes | 2021-2025 | 169 | CA 9 | 96.67 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 248 | CA 6 | 94.09 |
| Pharmacology and Obesity Treatment | 2021-2025 | 168 | CA 13 | 87.28 |
| Diabetes and associated disorders | 2021-2025 | 790 | CA 20 | 87.02 |
| GDF15 and Related Biomarkers | 2021-2025 | 513 | CA 16 | 57.52 |
| Nuclear Receptors and Signaling | 2021-2025 | 981 | CA 37 | 46.19 |
